100
Participants
Start Date
October 31, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
June 30, 2028
Caffeine (200 mg)
Participants receive a single oral dose of 200 mg caffeine under fasting conditions. Blood samples are collected before and three hours after intake to evaluate effects on hematopoietic stem and progenitor cells, including mobilization, function, gene expression, and metabolism.
ETH GLC, Zurich
ETH Zurich
OTHER
Laboratory of Stem Cell Biology and Ageing, ETH Zurich, Prof. Nina Cabezas-Wallscheid
UNKNOWN
Prof. Dr. Nina Cabezas-Wallscheid, ETH Zurich
UNKNOWN
Jasmin Rettkowski
OTHER